LifeMDLFMD
LFMD
About: LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
Employees: 336
0
Funds holding %
of 7,425 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
63% more call options, than puts
Call options by funds: $775K | Put options by funds: $476K
50% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 26
47% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 15
6% more funds holding
Funds holding: 100 [Q3] → 106 (+6) [Q4]
2.77% less ownership
Funds ownership: 39.82% [Q3] → 37.05% (-2.77%) [Q4]
12% less capital invested
Capital invested by funds: $89.9M [Q3] → $79.4M (-$10.5M) [Q4]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$14
69%
upside
Avg. target
$14.50
76%
upside
High target
$15
82%
upside
2 analyst ratings
2 positive
100%
0 neutral
0%
0 negative
0%
HC Wainwright & Co. Yi Chen 32% 1-year accuracy 55 / 170 met price target | 69%upside $14 | Buy Reiterated | 30 Apr 2025 |
Cantor Fitzgerald Sarah James 33% 1-year accuracy 32 / 96 met price target | 82%upside $15 | Overweight Reiterated | 11 Mar 2025 |
Financial journalist opinion
Based on 9 articles about LFMD published over the past 30 days
Neutral
Seeking Alpha
4 days ago
LifeMD, Inc. (LFMD) Q1 2025 Earnings Call Transcript
LifeMD, Inc. (NASDAQ:LFMD ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Justin Schreiber - Chairman and CEO Marc Benathen - Chief Financial Officer Conference Call Participants David Larsen - BTIG Sarah James - Cantor Fitzgerald Steve Dechert - KeyBanc Steven Valiquette - Mizuho Securities Yi Chen - H.C. Wainwright Anderson Schock - B.
Positive
Zacks Investment Research
5 days ago
LifeMD, Inc. (LFMD) Q1 Earnings and Revenues Top Estimates
LifeMD, Inc. (LFMD) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to loss of $0.19 per share a year ago.
Neutral
GlobeNewsWire
5 days ago
LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance
Total revenues increased 49% year-over-year to $65.7 million with telehealth revenue up 70% Adjusted EBITDA increased to $8.7 million from $0.1 million in the year-ago period Telehealth adjusted EBITDA increased to $5.3 million from a loss of $1.3 million in the year-ago period GAAP net income of $0.6 million or $0.01 per diluted share, delivering first-ever quarter of positive GAAP EPS Raising full-year 2025 guidance for both total revenues and adjusted EBITDA, reflecting strong year-to-date performance in telehealth Conference call begins at 4:30 p.m. Eastern time today NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today reported financial results for the three months ended March 31, 2025.
Positive
The Motley Fool
1 week ago
Why Hims & Hers Health and LifeMD Are Skyrocketing Today
Shares of Hims & Hers Health (HIMS 25.46%) and LifeMD (LFMD 35.41%) are surging on Tuesday. The companie' stocks had jumped 24% and 34%, respectively, as of 3:15 p.m.
Neutral
GlobeNewsWire
1 week ago
LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announced plans to offer broad, affordable, and streamlined access to Wegovy® (semaglutide) through NovoCare® Pharmacy. This integration offers a simplified pathway for cash-pay patients to access all FDA-approved dose strengths of Wegovy® directly within LifeMD's virtual care platform.
Neutral
GlobeNewsWire
1 week ago
LifeMD to Report First Quarter 2025 Financial Results on May 6
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2025 after the close of the U.S. financial markets on May 6, 2025 and will host a conference call beginning at 4:30 p.m. Eastern time.
Neutral
Business Wire
1 week ago
Medifast Announces First Quarter 2025 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2025. First Quarter 2025 Revenue of $115.7 million, with revenue per active earning coach of $4,556 Independent active earning OPTAVIA coaches of 25,400 Net loss of $0.8 million, which includes an unrealized gain on investment in LifeMD (Nasdaq: LFMD) common stock of $0.4 million (n.
Neutral
GlobeNewsWire
1 week ago
LifeMD Acquires Women's Health Provider Optimal Human Health MD to Accelerate Entry into the Women's Health Market
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the acquisition of key assets from Optimal Human Health MD (“Optimal”), a nationwide women's health virtual care provider. This strategic acquisition marks LifeMD's official entry into the women's health market and establishes a scalable clinical foundation for a comprehensive virtual health program under the LifeMD brand, focused on hormone health, bone density, metabolism, and long-term wellness.
Neutral
GlobeNewsWire
3 weeks ago
LifeMD Expands Insurance Acceptance to Medicare Beneficiaries for Qualifying Virtual Primary Care, Including in its Weight Loss Programs
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced expanded acceptance of insurance to Medicare beneficiaries for qualifying care. Initially available to more than 21 million Medicare Part B beneficiaries in 26 states, the company expects to expand access to medically necessary services for more than 60 million Medicare beneficiaries nationwide, with access to qualifying services across 49 states anticipated by the end of the second quarter.
Positive
Seeking Alpha
1 month ago
LifeMD Is Back To Life
LifeMD's weight management segment is regaining competitiveness due to the end of GLP-1 compound shortages and expanded insurance coverage, including Medicare. The company is seeing significant growth in its virtual care platform, with Q4 revenues up 43% and core telehealth revenues up 60%. LifeMD is expanding its insurance coverage, aiming to cover 150M lives by 2025, and launching new products in behavioral and women's health.
Charts implemented using Lightweight Charts™